Trans-Tenon's retrobulbar triamcinolone infusion for myopic choroidal neovascularization

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 6, 2006, Pages 749-754

  Kojima, Arik ^a   Ohno Matsui, Kyoko ^a   Futagami, Soh ^a   Shimada, Noriaki ^a   Tokoro, Takashi ^a   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Choroidal neovascularization; High myopia; Triamcinolone acetonide

Indexed keywords

CARBONATE DEHYDRATASE INHIBITOR; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; LONG TERM CARE; MALE; MYOPIA; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PRIORITY JOURNAL; RETINA EDEMA; RETINA MACULA DEGENERATION; SCANNING LASER OPHTHALMOSCOPY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; CHOROIDAL NEOVASCULARIZATION; FASCIA; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; ORBIT; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 33750607136     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00745.x     Document Type: Article

References (26)

1. Arndt CF, Sari A, Ferre M et.al. (2001): Electrophysiological effects of corticosteroids on the retinal pigment epithelium. Invest Ophthalmol Vis Sci 42: 472-475.
2. Avila MP, Weiter JJ, Jalkh AE et.al. (1984): Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91: 1573-1581.
3. CarnucAio R, Di Rosa M, Guerrasio B et.al. (1987): Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein. Br J Pharmacol 90: 443-445.
4. Curtin BJ (1985): The Myopias: Ocular Findings and Complications. Philadelphia: Harper & Row 277-347.
5. Curtin BJ & Karlin DB (1971): Axial length measurements and fundus changes of the myopic eye. Am J Ophthalmol 71: 42-50.
6. Dal Canto AJ, Downs-Kelly E & Perry JD (2005): Ptosis and orbital fat prolapse after posterior sub-Tenon's capsule triamcinolone injection. Ophthalmology 112: 1092-1097.
7. Danis RP, Bingaman DP, Yang Y & Ladd B (1996): Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 103: 2099-2104.
8. Gallardo MJ & Johnson DA (2004): Cutaneous hypopigmentation following a posterior sub-Tenon triamcinolone injection. Am J Ophthalmol 137: 779-780.
9. Ghafour IM, Allan D & Fould WS (1983): Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 67: 209-213.
10. Hampton GR, Kohen D & Bird AC (1983): Visual prognosis of disciform degeneration in myopia. Ophthalmology 90: 923-926.
11. Hayashi K, Ohno-Matsui K, Yoshida T et.al. (2005): Characteristics of patients with a favourable natural course of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 243: 13-19.
12. Koutsandrea CN, Miceli MV, Peyman GA et.al. (1991): Ciprofloxacin and dexamethasone inhibit the proliferation of human retinal pigment epithelial cells in culture. Curr Eye Res 10: 249-258.
13. Kramer M, Ehrlich R, Snir M et.al. (2004): Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease. Am J Ophthalmol 138: 666-667.
14. Kuo HK, Lai IC, Fang PC & Teng MC (2005): Ocular complications after a sub-Tenon injection of triamcinolone acetonide for uveitis. Chang Gung Med J 28: 85-89.
15. Lafranco Dafflon M, Tran VT, Guex-Crosier Y & Herbort CP (1999): Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: Indications, efficacy and side-effects. Graefes Arch Clin Exp Ophthalmol 237: 289-295.
16. Levin DS, Han DP, Dev S et.al. (2002): Sub-Tenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation. Am J Ophthalmol 133: 196-202.
17. Macular Photocoagulation Study Group (1991): Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 109: 1242-1257.
18. Moshfeghi DM, Lowder CY, Roth DB & Kaiser PK (2002): Retinal and choroidal vascular occlusion after posterior sub-Tenon triamcinolone injection. Am J Ophthalmol 134: 132-134.
19. Oh H, Takagi H, Takagi C et.al. (1999): The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 40: 1891-1898.
20. Okada AA, Wakabayashi T, Kojima E, Asano Y & Hida T (2004): Trans-Tenon's retrobulbar triamcinolone infusion for small choroidal neovascularization. Br J Ophthalmol 88: 1097-1098.
21. Okada AA, Wakabayashi T, Morimura Y et.al. (2003): Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis. Br J Ophthalmol 87: 968-971.
22. Proia A, Hirakata A, McInnes J et.al. (1993): The effect of angiostatic steroids and B-cyclodextrin tetradecasulfate on corneal neovascularization in the rat. Exp Eye Res 57: 693-698.
23. Spaide RF, Sorenson J & Maranan L (2003): Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110: 1517-1525.
24. Sperduto RD, Seigel D, Roberts J & Rowland M (1983): Prevalence of myopia in the United States. Arch Ophthalmol 101: 405-407.
25. Wang Y, Friedrichs U, Eichler W et.al. (2002): Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells. Graefes Arch Clin Exp Ophthalmol 240: 42-48.
26. Yoshida T, Ohno-Matsui K, Yasuzumi K et.al. (2003): Myopic choroidal neovascularization. A 10-year follow-up. Ophthalmology 110: 1297-1305.